SEC Form 4 · accession 0001354488-16-008686
TENAX THERAPEUTICS, INC. · TENX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael B Jebsen
Officer — Chief Financial Officer
Period of report
Dec 15, 2016
Accepted (ET)
Dec 20, 2016 · 3:15 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000034956
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $2.07 | Dec 15, 2016 | A | 150,000 | A | — | Dec 15, 2026 | Common Stock | 150,000 | 150,000 | D |
Explanation of responses
- F1This option vests and becomes exercisable in four equal annual installments beginning on December 15, 2017.